As advised via Pharmac decision announced 30 April 2018 there is to be a change in the listing and future sole supply.

New listing from 1 November 2018

Tamoxifen Sandoz Tab 10 mg 60                                  Pharmacode  2556944              Schedule price $11.75

Tamoxifen Sandoz Tab 20 mg 60                                  Pharmacode  2556952              Schedule price $5.60

Incumbent brand

Genox Tab 10 mg 100                                                      Pharmacode 2130955          Schedule price $19.50

Genox Tab 20 mg 100                                                     Pharmacode 2130963          Schedule price $12.50

Reference pricing will apply to incumbent (20 mg only) from 1 January 2019

HML (Hospital Supply Status) commences 1 January 2019 and CSS (Community Supply Status) commences 1 April 2019.

As of the date of this notification ProPharma / PWR cannot accept Genox Tab 10 mg or 20 mg for credit under any circumstances.

We would recommend you continue to purchase the incumbent and we will change automatically as existing stocks are exhausted.

Benefit of staying with incumbent – With a variable or reducing margin every cent counts.

10 mg:-  $19.50 x 3% = $0.585 plus $0.2530 per pack fee = $0.838  compared to $11.75 x 3% = $0.3525 plus $0.4048($0.253 x 1.6) per pack fee = $0.7573

20 mg:- $12.50 x 3% = $0.375 plus $0.253 per pack fee = $0.6280 compared to $5.60 x  3% = $0.168 plus $0.4048 ($0.2530 x 1.6) per pack fee = $0.5728

You simply need to manage your stock so that you have ZERO stock at time of reference pricing being 1 January 2019.

Once again we need your support to ensure stock in the supply chain moves through, to effectively ensure no losses are incurred.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author

Close